Wednesday, 24 April 2024

 

 

LATEST NEWS PM Modi synonymous with trust, hope, credibility: Devender Singh Rana Atal Dulloo reviews the working & Public Outreach activities of Information Department General, Police Observer interact with Zonal, Sectoral Magistrates, BLOs of district Reasi Div Com Jammu, ADGP visit Rajouri, review preparations for elections Lt Governor addresses seminar on National Education Policy 2020 at Ghazipur DC Bandipora Shakeel ul Rehman Rather reviews Floriculture, Fisheries, Sericulture Departments DC Bandipora Shakeel ul Rehman Rather reviews performance of AHD DC Bandipora Shakeel ul Rehman Rather reviews Agriculture Sector DEO Bandipora Shakeel ul Rehman Rather inspects EVM, material strong room DEO Bandipora Shakeel ul Rehman Rather reviews poll preparedness Harnit Singh Sudan (IAS 2023) Interacts with IAS/JKAS Aspirants Marathon under SVEEP held at Samba to maximize voter awareness DEO Kupwara reviews transportation of polling staff, EVMs DEO Kulgam flags-off cycle rally under SVEEP to raise voter awareness 5 more candidates file nominations for Srinagar Lok Sabha seat TV Serial Actor Abhinav Shukla Net Worth 2024 | 5 Dariya News DC visits Lalton & Jodhan grain markets to oversee wheat procurement DC orders officers to intensify field visits for smooth procurement operations at ground level Punjab Police Averts Possible Target Killing In J&K; One Member Of Pak-Based Terror Module Held District Administrative Complex Mohali to Spread the Message of Voting Anil Vij Lauds Lord Mahavir Jain Public School's Commitment to Education

 

'Mild' link between Pfizer, Moderna jabs & heart inflammation: WHO

Delta Plus Covid variant, Delta Covid-19 variant, Health, Study, Coronavirus, Research, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Remdesivir, Geneva, World Health Organisation, WHO
Listen to this article

Web Admin

Web Admin

5 Dariya News

Geneva , 11 Jul 2021

The World Health Organisation (WHO) has found very rare cases of heart inflammation following vaccination with the mRNA Covid-19 vaccines such as Pfizer and Moderna, but the benefits still outweigh the risks.The cases were mild, and found more often in young men after the second dose, said the global health body.WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that cases of myocarditis and pericarditis had been reported in the US and several other countries. Myocarditis is an inflammation of the heart muscle, while pericarditis is an inflammation of the lining that surrounds the heart."Very rare cases of myocarditis and pericarditis have been observed following vaccination with the mRNA Covid-19 vaccines. These cases occurred more often in younger men and after the second dose of the vaccine, typically within a few days after vaccination. Current evidence suggests a likely causal association between myocarditis and the mRNA vaccines," the WHO said in a statement.The available data also suggest that the immediate cause of myocarditis and pericarditis following vaccination is generally mild and responds to rest, treatment with nonsteroidal anti-inflammatory drugs, etc.Nearly 40.6 cases of myocarditis per million second doses among males and 4.2 cases per million among females have been reported as of June 11, 2021 in people aged between 12 and 29 years who received the mRNA Covid-19 vaccines, according to the data in the US Vaccine Adverse Events Reporting System (VAERS).For persons over 30 years of age, the reporting rates were 2.4 and 1.0 per million second doses, respectively, for males and females.The link was also confirmed by the European Medicines Agency, Europe's drug regulator.EMA's Pharmacovigilance Risk Assessment Committee (PRAC) confirmed "a plausible causal relationship between myocarditis and the mRNA vaccines" in Europe.Yet, "the benefits of mRNA Covid-19 vaccines continue to outweigh the risks of myocarditis and pericarditis even among young people, the WHO said.Symptoms indicative of myocarditis or pericarditis include new onset and persisting chest pain, shortness of breath, or palpitations following vaccination.The global health body advised clinicians to be aware of the risk of myocarditis and pericarditis with mRNA vaccines and people most likely to be affected -- adolescent or young males. It also asked vaccinated individuals to seek immediate medical attention if they develop any such conditions.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Health , Study , Coronavirus , Research , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Remdesivir , Geneva , World Health Organisation , WHO

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD